Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 2

1(33.3%)

3Total

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05553236Not ApplicableRecruiting

Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis

Role: collaborator

NCT06114628Phase 2Recruiting

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

Role: collaborator

NCT05684887Not ApplicableCompleted

Digital Tools to Expand COVID-19 Testing in Exposed Individuals in Cameroon

Role: collaborator

NCT05458557Completed

Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus 2

Role: collaborator

NCT04232618Unknown

Point-of-care Triage Test for Active Tuberculosis

Role: collaborator

NCT03025516Unknown

Performance Evaluation of TB Breath- and Cough-testing Platforms

Role: lead

All 6 trials loaded